Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Shilpa Medicare Ltd

SHILPAMED.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Small Cap Analyst: BUY

Last Close

$8.61

▲ +1.85%

Market Cap $1.68B · Vol 1.04M

Key Metrics

P/E Ratio

53.78

FWD: 49.32

Market Cap

$1.68B

Small Cap

Div Yield

0.07%

Annual dividend

EPS Growth

+25.64%

YoY

RSI (14)

87.90

Momentum

Beta

0.62

vs Market

52W High

$8.65

0.42% below

52W Low

$2.72

203.53% above

Volume

1.04M

Avg 2.29M

P/B

N/A

Price-to-book

ROE

9.00%

Return on equity

Free Float

42.98%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Shilpa Medicare Ltd (SHILPAMED.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does SHILPAMED.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+8.19%

+31.68%

+82.46%

+151.53%

YTD

+155.96%

+80.93%

+325.50%

+174.16%

Financials & Valuation

TTM · Annual

Total Revenue	$164.66M
Net Income	$26.04M
Revenue Growth (YoY)	+44.90%
Gross Margin	53.17%
Operating Margin	N/A
Net Profit Margin	N/A
ROE	9.00%
ROA · ROIC	8.42% · N/A

P/E Ratio	53.78
Forward P/E (FY1)	49.32
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	+25.64%
Outstanding Shares	195.58M

Technical Indicators

50-Day SMA	$6.53
200-Day SMA	$4.47
RSI (14)	87.90
Beta	0.62
52-Week High	$8.65
52-Week Low	$2.72

Volume Today	1.04M
Avg Daily Volume (30D)	2.29M
Relative Volume	0.45x
Volatility (10D)	53.44
Volatility (30D)	46.52
Free Float	42.98%

Analyst Consensus

BUY

Current Price $8.61

Mean Target $8.15

52W Low$2.72 52W High$8.65

Current

Target

$2.72 $8.65

Current Analyst target

-5.43% downside risk · 3 analysts

Identifiers

ExchangeNSE India

FIGIBBG001S5RFL9

ISININE790G01031

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateNov 11, 2026

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Shilpa Medicare Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of active pharmaceutical ingredients (APIs), formulation and development service. It is engaged in APIs, intermediates, formulations, new drug delivery systems, peptides / biotech products and specialty chemicals, and others. The Company supplies more than 30 oncology APIs including key products such as Capecitabine, Gemcitabine Hydrochloride, Pemetrexed, Axitinib, Erlotinib Hydrochloride and Irinotecan Hydrochloride for various international markets including United States of America, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets. Its non-Oncology API products include Ambroxol (Mucolytic agent), Tranexmic Acid and Ursodeoxycholic Acid. Its Injectable Dosage Forms include Myelodysplastic Syndrome, Breast Cancer, Multiple Myeloma, and more. Its Oral Solid Dosage Forms include Psoriasis, Prostate Cancer, Multiple Sclerosis, and others.